The Plasmatic Activity Changes of Tissue-type Plasminogen Activator and Type 1 Plasminogen Activator Inhibitor in Patients with Arteriosclerotic Cerebral Infarction and Its Clinical Significance
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To explore the dynamic changes of the plasmatic activities of tPA and PAI-1 and its clinical significance by observing the plasmatic activity of tPA and PAI-1 in acute and recovery phases of the patients with arteriosclerotic cerebral infarction (ACI). Methods The plasmatic activities of tPA and PAI-1 were determined by Chromgenic Substrate methods in 91 patients with ACI and 40 normal old ages as control, while the infarction volume and the neurological damage score in those with ACI were measured. Results The plasmatic activities of tPA in acute and recovery periods of the patients with ACI was 0.26±0.14and0.21±0.11 kIU/L respectively and was significantly lower than those of the control subjects ( P< 0.01), and the plasmatic activities of PAI-1 in acute and recovery periods of the patients with ACI were 0.90 ± 0.25 and 0.98 ± 0.12 kAU/ L respectively and were significantly higher than those of the control subjects ( P< 0.01), while the infarction volume and the neurological damage score in those with ACI were 8.75 ± 1.21 cm and 18.56 ± 3.62 respectively, and the plasmatic activity of tPA was negatively related to the infarction volume and the neurological damage score in those with ACI (r = - 0.5133, P< 0. 05 and r = - 0.4914, P< 0.05 respectively ), and the plasmatic activity of PAI-1 was positively related to the infarction volume and the neurological damage score in those with ACI(r = 0.5621, p< 0.05 and r = 0.5342, p< 0.05 respectively). Conclusions The fibrinolysis activities of the acute and recovery periods of the patients with ACI decline significantly, which suggests that tPA and PAI-1 play an important role in the pathological process of arteriosclerotic cerebral infarction.

    Reference
    Related
    Cited by
Get Citation

DU Xiao-Rng, WAN Wei-Min, YANG Qi-Dong, ZHANG Le,,LIU Zun-Jing. The Plasmatic Activity Changes of Tissue-type Plasminogen Activator and Type 1 Plasminogen Activator Inhibitor in Patients with Arteriosclerotic Cerebral Infarction and Its Clinical Significance[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2004,12(3):339-342.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 20,2003
  • Revised:February 23,2004
Article QR Code